 |
Kahr Medical
Last updated: January 22, 2024
Yaron Pereg - CEO
Country: Israel | Funding: $101.5M (+)
Website: https://kahrbio.com/
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
Website: https://kahrbio.com/
KAHR Medical develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
